Yongjie Shui
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 5
-
- Lung Cancer Research Studies 3
-
- Cancer-related molecular mechanisms research 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 3
-
- Glioma Diagnosis and Treatment 3
- Journals
- Journal of Clinical Oncology (1 paper)Frontiers in Immunology (1 paper)Annals of Surgical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yongjie Shui
31 papers receiving 641 citations
Peers
Comparison fields: 5 of 81
- Hepatology 106
- Otorhinolaryngology 47
- Oncology 206
- Cancer Research 75
- Biological Psychiatry 12
Countries citing papers authored by Yongjie Shui
This map shows the geographic impact of Yongjie Shui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjie Shui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjie Shui more than expected).
Fields of papers citing papers by Yongjie Shui
This network shows the impact of papers produced by Yongjie Shui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjie Shui. The network helps show where Yongjie Shui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongjie Shui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 27 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 155 | |
| 7 | 2021 | 9 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 21 | |
| 11 | 2018 | 66 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 0 | |
| 15 | 2016 | 25 | |
| 16 | 2016 | 11 | |
| 17 | 2014 | 7 | |
| 18 | 2008 | 53 | |
| 19 | 2008 | 27 | |
| 20 | 2008 | 30 |
About Yongjie Shui
Yongjie Shui is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 32 papers that have together received 648 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (5 papers), Cancer-related molecular mechanisms research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Brain Metastases and Treatment (3 papers), Glioma Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Hepatology (106 citations), Otorhinolaryngology (47 citations) and Oncology (206 citations). Yongjie Shui has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Qichun Wei, Liming Sheng, Li Shen, Xiaoqiu Ren, Dongjun Dai, Kejing Wang, Jinfan Li, Hans Nordgren, Jörgen Carlsson and Yinglu Guo. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.